Cargando…
Fahr Syndrome Secondary to Pseudohypoparathyroidism
Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690847/ https://www.ncbi.nlm.nih.gov/pubmed/38045865 http://dx.doi.org/10.1210/jcemcr/luad147 |
_version_ | 1785152609938571264 |
---|---|
author | Shu, Sharon W Sharma, Sakshi Iqbal, Qasim Z Romo, Karina G |
author_facet | Shu, Sharon W Sharma, Sakshi Iqbal, Qasim Z Romo, Karina G |
author_sort | Shu, Sharon W |
collection | PubMed |
description | Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at target organs, is associated with Fahr syndrome and typically presents with hypocalcemia. The following case presents a 39-year-old-woman with PHP complicated by symptomatic hypocalcemia, hypokalemia, and movement disturbances, who had computed tomography imaging showing basal ganglia calcifications consistent with Fahr syndrome. She initially presented with headache and was hospitalized for hypertensive emergency and severe hypocalcemia. Examination, including the neurologic examination, was unrevealing aside from hypertension and central adiposity. Laboratory tests were consistent with PHP, showing hypocalcemia with elevated PTH, and negative for hyperaldosteronism. Management of hypocalcemia consisted of intravenous calcium infusion, oral calcium carbonate, oral vitamin D3, and oral calcitriol. Patients with severe hypocalcemia and elevated PTH who present with new neurological symptoms despite normal general neurologic examination may warrant consideration for brain imaging to evaluate for Fahr syndrome. Further investigations are necessary to determine the prevalence of Fahr syndrome and hypokalemia in patients with PHP, explore if these findings are significantly associated with PHP-1b subtype, and ultimately inform potential new screening pathways for these patients. |
format | Online Article Text |
id | pubmed-10690847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106908472023-12-02 Fahr Syndrome Secondary to Pseudohypoparathyroidism Shu, Sharon W Sharma, Sakshi Iqbal, Qasim Z Romo, Karina G JCEM Case Rep Case Report Fahr syndrome is a rare neurologic disorder, usually affecting young and middle-aged adults, that can present with symptoms ranging from extrapyramidal to neuropsychiatric abnormalities. Pseudohypoparathyroidism (PHP), characterized by parathyroid hormone (PTH)-resistance or PTH-unresponsiveness at target organs, is associated with Fahr syndrome and typically presents with hypocalcemia. The following case presents a 39-year-old-woman with PHP complicated by symptomatic hypocalcemia, hypokalemia, and movement disturbances, who had computed tomography imaging showing basal ganglia calcifications consistent with Fahr syndrome. She initially presented with headache and was hospitalized for hypertensive emergency and severe hypocalcemia. Examination, including the neurologic examination, was unrevealing aside from hypertension and central adiposity. Laboratory tests were consistent with PHP, showing hypocalcemia with elevated PTH, and negative for hyperaldosteronism. Management of hypocalcemia consisted of intravenous calcium infusion, oral calcium carbonate, oral vitamin D3, and oral calcitriol. Patients with severe hypocalcemia and elevated PTH who present with new neurological symptoms despite normal general neurologic examination may warrant consideration for brain imaging to evaluate for Fahr syndrome. Further investigations are necessary to determine the prevalence of Fahr syndrome and hypokalemia in patients with PHP, explore if these findings are significantly associated with PHP-1b subtype, and ultimately inform potential new screening pathways for these patients. Oxford University Press 2023-12-01 /pmc/articles/PMC10690847/ /pubmed/38045865 http://dx.doi.org/10.1210/jcemcr/luad147 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Shu, Sharon W Sharma, Sakshi Iqbal, Qasim Z Romo, Karina G Fahr Syndrome Secondary to Pseudohypoparathyroidism |
title | Fahr Syndrome Secondary to Pseudohypoparathyroidism |
title_full | Fahr Syndrome Secondary to Pseudohypoparathyroidism |
title_fullStr | Fahr Syndrome Secondary to Pseudohypoparathyroidism |
title_full_unstemmed | Fahr Syndrome Secondary to Pseudohypoparathyroidism |
title_short | Fahr Syndrome Secondary to Pseudohypoparathyroidism |
title_sort | fahr syndrome secondary to pseudohypoparathyroidism |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690847/ https://www.ncbi.nlm.nih.gov/pubmed/38045865 http://dx.doi.org/10.1210/jcemcr/luad147 |
work_keys_str_mv | AT shusharonw fahrsyndromesecondarytopseudohypoparathyroidism AT sharmasakshi fahrsyndromesecondarytopseudohypoparathyroidism AT iqbalqasimz fahrsyndromesecondarytopseudohypoparathyroidism AT romokarinag fahrsyndromesecondarytopseudohypoparathyroidism |